In Brief: Avobenzone
This article was originally published in The Tan Sheet
Executive Summary
Avobenzone: BASF expresses support for FDA's proposed GRAS/E designation of the sunscreen ingredient avobenzone in Oct. 17 comments ("The Tan Sheet" Sept. 23, p. 15). The company, however, complained that the omission of "foreign marketing experience with avobenzone...implicitly suggests that such data is inadequate." The comments assert that "FDA must accept foreign product marketing experience" and cite FDA's recent advance notice of proposed rulemaking that would allow foreign data based on "material time, material extent" criteria ("The Tan Sheet" Oct. 7, p. 1)...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning